Are you a journalist?

Learn to know ALK

If you have any queries please feel free to contact Media Relations at ALK headquarters or one of our global offices.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

News

  • Post date
    08/14/2025
    Invitation to the presentation of ALK’s first six months (Q2) 2025 results on Thursday, 21 August 2025
  • Post date
    08/12/2025
    ALK upgrades its full-year revenue outlook
  • Post date
    07/21/2025
    ALK’s tree pollen tablet (ITULAZAX®) now recommended by NICE for use in the UK health system
  • Post date
    07/18/2025
    EURneffy® approved as the first needle-free anaphylaxis treatment of adults and children in the UK
  • Post date
    06/26/2025
    First market launch of the adrenaline nasal spray, EURneffy®, for treatment of adults and children in Germany
  • Post date
    06/16/2025
    ALK presented comprehensive data on two new paediatric AIT tablets and a nasal adrenaline spray at EAACI 2025
  • Post date
    06/04/2025
    ALK participates at Jefferies Global Healthcare Conference 2025 in New York
  • Post date
    05/08/2025
    ITULATEK® approved for treatment of children and adolescents in Canada
  • Post date
    05/06/2025
    Three-month interim report (Q1) 2025 (unaudited)

Media Relations

Per Plotnikof
Vice President,
Corporate Communications,
Investor Relations and Strategic Planning
Phone: +45 22612525
Email: PPIDK@alk.net

Jeppe Ilkjær
Media Relations Manager
Corporate Communications
Phone: +45 30502014
Email: Jeppe.Ilkjaer@alk.net

Journalists are always welcome to contact ALK’s Media Relations team.
Steen Riisgaard, CEO
Production facilities, Hørsholm
Image
alk_produktion6_0
Production facilities, Hørsholm
Image
alk_produktion3_1
Production facilities, Hørsholm
Image
alk_produktion5
Production facilities, Hørsholm
Image
Family_website_0
ALK HQ, Hørsholm
Last updated: 2016.11.14